Evidence map›Paper›PMID 33954257›Full record

ArticleOpen medicine (Warsaw, Poland)2021

Maria Araceli Diaz Cruz, Dan Lund, Ferenc Szekeres, Sandra Karlsson, Maria Faresjö, Dennis Larsson

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Maria Araceli Diaz CruzResearch School of Health and Welfare, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Dan LundDepartment of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Ferenc SzekeresDepartment of Biomedicine, School of Health Sciences, University of Skövde, Skövde, Sweden.
Sandra KarlssonDepartment of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Maria FaresjöDepartment of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Dennis LarssonSahlgrenska University Hospital, Gothia Forum for Clinical Research, Gothenburg, Sweden.
Jönköping University · SESahlgrenska University Hospital · SEUniversity of Skövde · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear receptors (NRs) are ligand-activated transcription factors that regulate gene expression when bound to specific DNA sequences. Crosstalk between steroid NR systems has been studied for understanding the development of hormone-driven cancers but not to an extent at a genetic level. This study aimed to investigate crosstalk between steroid NRs in conserved intron and exon sequences, with a focus on steroid NRs involved in prostate cancer etiology. For this purpose, we evaluated conserved intron and exon sequences among all 49 members of the NR Superfamily (NRS) and their relevance as regulatory sequences and NR-binding sequences. Sequence conservation was found to be higher in the first intron (35%), when compared with downstream introns. Seventy-nine percent of the conserved regions in the NRS contained putative transcription factor binding sites (TFBS) and a large fraction of these sequences contained splicing sites (SS). Analysis of transcription factors binding to putative intronic and exonic TFBS revealed that 5 and 16%, respectively, were NRs. The present study suggests crosstalk between steroid NRs, e.g., vitamin D, estrogen, progesterone, and retinoic acid endocrine systems, through

Indexed as

conserved sequencescrosstalknuclear receptor binding domainssplicing sitestranscription factor binding sites

Identifiers

PMID33954257
PMCPMC8051167
OpenAlexW3154033887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.